Please assess the completion status of the following clinical trial:

Trial Title: An Observational Study of NeoRecormon (Epoetin Beta) in Cancer Patients With Anemia (FAST)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Adult patients, \>/=18 years of age~* Patients receiving myelosuppressive chemotherapy for a solid tumor, a hematological malignancy or an autograft for hematological malignancy~* Patients for whom treatment with epoetin beta is started at the inclusion visit~* Life expectancy \>/=6 months according to the physician~* Patients accepting and able to complete a French written questionnaire about his/her professional and social activities at each visit~Exclusion Criteria:~* Patients who received erythropoiesis-stimulating agents treatment, or red blood cell transfusion within 4 weeks before enrollment~* Participation in a clinical trial in onco-hematology~* Patients with myelodysplasia~* Patients with more than one active malignancy at the time of enrollment

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cohort (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).